0001628280-21-020527.txt : 20211026 0001628280-21-020527.hdr.sgml : 20211026 20211026163324 ACCESSION NUMBER: 0001628280-21-020527 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211025 FILED AS OF DATE: 20211026 DATE AS OF CHANGE: 20211026 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Huizinga Robert Bindert CENTRAL INDEX KEY: 0001837648 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36421 FILM NUMBER: 211349016 MAIL ADDRESS: STREET 1: #1203-4464 MARKHAM STREET CITY: VICTORIA STATE: A1 ZIP: BC V8Z7X8 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Aurinia Pharmaceuticals Inc. CENTRAL INDEX KEY: 0001600620 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: A0 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: #1203-4464 MARKHAM STREET CITY: VICTORIA BC STATE: A1 ZIP: V8Z 7X8 BUSINESS PHONE: 250-708-4272 MAIL ADDRESS: STREET 1: #1203-4464 MARKHAM STREET CITY: VICTORIA BC STATE: A1 ZIP: V8Z 7X8 4 1 wf-form4_163528039067523.xml FORM 4 X0306 4 2021-10-25 0 0001600620 Aurinia Pharmaceuticals Inc. AUPH 0001837648 Huizinga Robert Bindert #1203-4464 MARKHAM STREET VICTORIA A1 V8Z7X8 BRITISH COLUMBIA, CANADA 0 1 0 0 EVP of Research Common Stock 2021-10-25 4 M 0 95000 3.20 A 195728 D Common Stock 2021-10-25 4 S 0 130000 29.75 D 65728 D Stock Option (right to buy) 3.2 2021-10-25 4 M 0 95000 0 D 2027-02-09 Common Stock 95000.0 3864 D Converted to U.S. dollars based on the average daily exchange rate of the Bank of Canada reported on the grant date. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. The price in column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $29.50 to $30.07, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. The shares subject to the option are fully vested and immediately exercisable. They vested in thirty-six equal monthly installments from the grant date. /s/ Robert Bindert Huizinga 2021-10-26